OCGN Competitors & Alternatives
Compare Ocugen Inc with similar stocks in the same industry
Biotechnology
OCGN
Main Stock$1.51
Tradestie Score
57
Market Cap
$524.67M
Revenue Growth
0.0%
Analyst Upside
+656.9%
Top Competitors
236 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
PRTA
Prothena Corporation plc Ordinary Shares
|
$9.69
|
$533.99M | - | 55 | Compare |
|
ZVRA
Zevra Therapeutics, Inc. Common Stock
|
$13.98
|
$529.35M | 6.9 | 62 | Compare |
|
MNPR
Monopar Therapeutics Inc. Common Stock
|
$97.79
|
$522.78M | - | 56 | Compare |
|
LXRX
Lexicon Pharmaceuticals, Inc.
|
$2.32
|
$512.39M | - | 59 | Compare |
|
RIGL
Rigel Pharmaceuticals Inc. (New)
|
$38.72
|
$505.12M | 2.0 | 54 | Compare |
|
RGNX
REGENXBIO Inc.
|
$13.28
|
$493.52M | - | 56 | Compare |
|
INBX
Inhibrx Biosciences, Inc. Common Stock
|
$97.58
|
$492.21M | - | 52 | Compare |
|
XOMA
XOMA Royalty Corporation Common Stock
|
$43.00
|
$474.20M | 27.1 | 59 | Compare |
|
ABSI
Absci Corporation Common Stock
|
$11.62
|
$468.01M | - | 52 | Compare |
|
GLUE
Monte Rosa Therapeutics, Inc. Common Stock
|
$24.21
|
$463.20M | - | 59 | Compare |
More OCGN Analysis
Data updated: Jul 05, 2026 | Industry: Biotechnology (SIC 2836)
236 stocks in this industry